News

Julie Rubinstein, President and COO of Adaptive Biotechnologies Corp (NASDAQ:ADPT), filed a Form 4 on November 6, 2026, disclosing option exercises and open-market share sales across three trading days from November 4 through November 6, 2026, all executed under a Rule 10b5-1 trading plan.

Morgan Stanley and its subsidiary Morgan Stanley Canada Limited filed an amended beneficial ownership statement on November 6, 2026, disclosing that both entities had fallen below five percent ownership of MDA Space Ltd. common shares as of October 31, 2026.

Nathan G. Brower, EVP and General Counsel of Natures Sunshine Products Inc (NASDAQ:NATR), filed a Form 4 on November 6, 2026, disclosing RSU vesting transactions and related tax-withholding disposals that occurred on November 4, 2026.

Jonathan David Lanoy, SVP and Chief Accounting Officer of Natures Sunshine Products Inc, filed a Form 4 on November 6, 2026, disclosing RSU vestings and related tax-withholding disposals of common shares on November 4, 2026.

AGNT, Inc. CEO Leonardo Pareja filed a Form 4 on November 6, 2026, disclosing the vesting of restricted stock units and a tax-withholding share disposition on the same date.

Daniel C. Norman, EVP and President, Asia at Natures Sunshine Products Inc (NASDAQ:NATR), filed a Form 4 on November 6, 2026, disclosing transactions dated November 4, 2026, involving the vesting of performance-based restricted stock units and the withholding of shares to cover taxes.

Jesse P. Hill, Chief Financial Officer of AGNT, Inc., filed a Form 4 on November 6, 2026, disclosing two transactions in common stock on November 5, 2026, related to the vesting of restricted stock units and a tax-withholding share disposition.